Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
Myriad Genetics has scheduled its first quarter 2025 earnings conference call for May 6, 2025, at 4:30 pm EDT. The company will release its Q1 2025 financial results after market close on the same day.
Investors can access the live webcast through investor.myriad.com. To join via telephone, participants must register to receive a dial-in number and unique PIN.
Additionally, Myriad's management will participate in two major healthcare investor conferences:
- BofA Securities 2025 Health Care Conference - Fireside chat on May 14, 2025, at 3:00 pm EDT
- Goldman Sachs 46th Annual Global Healthcare Conference - Fireside chat on June 11, 2025, at 2:00 pm EDT
Both conference presentations will be available for viewing through live and archived webcasts on the company's investor relations website.
Myriad Genetics ha programmato la conference call per la presentazione dei risultati del primo trimestre 2025 il 6 maggio 2025 alle 16:30 EDT. La società pubblicherà i risultati finanziari del Q1 2025 dopo la chiusura del mercato nello stesso giorno.
Gli investitori potranno seguire la diretta streaming su investor.myriad.com. Per partecipare telefonicamente, è necessario registrarsi per ricevere un numero di accesso e un PIN univoco.
Inoltre, la direzione di Myriad parteciperà a due importanti conferenze per investitori nel settore sanitario:
- BofA Securities 2025 Health Care Conference - Conversazione informale il 14 maggio 2025 alle 15:00 EDT
- Goldman Sachs 46ª Annual Global Healthcare Conference - Conversazione informale l'11 giugno 2025 alle 14:00 EDT
Entrambe le presentazioni saranno disponibili in diretta e in differita sul sito web delle relazioni con gli investitori della società.
Myriad Genetics ha programado su conferencia telefónica de resultados del primer trimestre de 2025 para el 6 de mayo de 2025 a las 16:30 EDT. La compañía publicará sus resultados financieros del Q1 2025 después del cierre del mercado ese mismo día.
Los inversores podrán acceder a la transmisión en vivo a través de investor.myriad.com. Para unirse por teléfono, los participantes deben registrarse para recibir un número de acceso y un PIN único.
Además, la dirección de Myriad participará en dos importantes conferencias para inversores en el sector salud:
- Conferencia de Salud 2025 de BofA Securities - Charla informal el 14 de mayo de 2025 a las 15:00 EDT
- 46ª Conferencia Global Anual de Salud de Goldman Sachs - Charla informal el 11 de junio de 2025 a las 14:00 EDT
Ambas presentaciones estarán disponibles para su visualización en transmisiones en vivo y archivadas en el sitio web de relaciones con inversores de la compañía.
Myriad Genetics는 2025년 1분기 실적 컨퍼런스 콜을 2025년 5월 6일 오후 4시 30분(EDT)에 예정하고 있습니다. 회사는 같은 날 장 마감 후 2025년 1분기 재무 결과를 발표할 예정입니다.
투자자들은 investor.myriad.com을 통해 생중계 웹캐스트에 접속할 수 있습니다. 전화 참여를 원할 경우, 참가자는 전화 접속 번호와 고유 PIN을 받기 위해 등록해야 합니다.
또한, Myriad 경영진은 두 개의 주요 헬스케어 투자자 컨퍼런스에 참석할 예정입니다:
- BofA Securities 2025 헬스케어 컨퍼런스 - 2025년 5월 14일 오후 3시(EDT) 화기애애한 대화
- Goldman Sachs 제46회 연례 글로벌 헬스케어 컨퍼런스 - 2025년 6월 11일 오후 2시(EDT) 화기애애한 대화
두 컨퍼런스 발표 모두 회사 투자자 관계 웹사이트에서 생중계 및 다시보기로 시청할 수 있습니다.
Myriad Genetics a programmé sa conférence téléphonique sur les résultats du premier trimestre 2025 le 6 mai 2025 à 16h30 EDT. La société publiera ses résultats financiers du T1 2025 après la clôture du marché ce même jour.
Les investisseurs peuvent accéder à la diffusion en direct via investor.myriad.com. Pour participer par téléphone, les participants doivent s'inscrire afin de recevoir un numéro d'appel et un code PIN unique.
De plus, la direction de Myriad participera à deux grandes conférences d'investisseurs dans le secteur de la santé :
- Conférence Santé 2025 de BofA Securities – Discussion informelle le 14 mai 2025 à 15h00 EDT
- 46e Conférence mondiale annuelle de la santé de Goldman Sachs – Discussion informelle le 11 juin 2025 à 14h00 EDT
Les deux présentations seront disponibles en direct et en replay sur le site des relations investisseurs de la société.
Myriad Genetics hat seine Telefonkonferenz zur Bekanntgabe der Ergebnisse für das erste Quartal 2025 für den 6. Mai 2025 um 16:30 Uhr EDT angesetzt. Das Unternehmen wird die Finanzergebnisse für Q1 2025 am selben Tag nach Börsenschluss veröffentlichen.
Investoren können den Live-Webcast über investor.myriad.com verfolgen. Für die telefonische Teilnahme müssen sich die Teilnehmer registrieren, um eine Einwahlnummer und eine individuelle PIN zu erhalten.
Außerdem wird das Management von Myriad an zwei wichtigen Investorenkonferenzen im Gesundheitswesen teilnehmen:
- BofA Securities 2025 Health Care Conference – Fireside-Chat am 14. Mai 2025 um 15:00 Uhr EDT
- Goldman Sachs 46. jährliche globale Gesundheitskonferenz – Fireside-Chat am 11. Juni 2025 um 14:00 Uhr EDT
Beide Präsentationen werden live und als Aufzeichnungen auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- Management's participation in two major healthcare investor conferences (BofA Securities and Goldman Sachs) indicates strong institutional interest and visibility
- Company maintains regular investor communication through scheduled earnings calls and conference participation
- None.
Management will participate in two upcoming investor healthcare conferences
SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the first quarter 2025.
A live webcast of the conference call can be accessed on Myriad’s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at investor.myriad.com following the call.
Upcoming Q2 Investor Conferences
Management plans to participate in the following investor healthcare conferences:
- The BofA Securities 2025 Health Care Conference – fireside chat at 3:00 pm EDT on Wednesday, May 14, 2025.
- Goldman Sachs 46th Annual Global Healthcare Conference – fireside chat at 2:00 pm EDT on Wednesday, June 11, 2025.
Live and archived webcasts of all presentations can be viewed at investor.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com
Media Contact
Kate Schraml
(224) 875-4493
PR@myriad.com
FAQ
When will Myriad Genetics (MYGN) release Q1 2025 earnings?
How can investors join Myriad Genetics Q1 2025 earnings call?
Which investor conferences will MYGN attend in Q2 2025?
Where can I watch Myriad Genetics (MYGN) investor conference presentations?
What time is Myriad Genetics BofA Securities conference presentation?
